國立虎尾科技大學 |

T-Cell and NK-Cell Lymphomas = From Biology to Novel Therapies /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	T-Cell and NK-Cell Lymphomas/ edited by Christiane Querfeld, Jasmine Zain, Steven T. Rosen.
Reminder of title:	From Biology to Novel Therapies /
other author:	Querfeld, Christiane.
Description:	VIII, 287 p. 40 illus., 37 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-3-319-99716-2
ISBN:	9783319997162

T-Cell and NK-Cell Lymphomas = From Biology to Novel Therapies /
T-Cell and NK-Cell LymphomasFrom Biology to Novel Therapies /[electronic resource] :edited by Christiane Querfeld, Jasmine Zain, Steven T. Rosen. - 1st ed. 2019. - VIII, 287 p. 40 illus., 37 illus. in color.online resource. - Cancer Treatment and Research,1760927-3042 ;. - Cancer Treatment and Research,165.

Epidemiology and Pathology of T cell lymphomas/NK cell lymphomas -- Molecular and genomic landscape -- Microenvironment -- PTCL, NOS -- AITL -- ALCL -- Adult T cell leukemia/lymphoma -- NK Cell lymphomas -- Hepatosplenic T cell lymphoma -- Rare subtypes e.g. gamma-delta T cell lymphoma -- Mycosis fungoides/Sézary syndrome -- CD30+ Lymphoproliferative disorders -- Transplantation. .

In this book, a group of internationally distinguished lymphoma experts provide a comprehensive review of the most important advances in the biology, diagnosis, and therapy of T cell and NK cell malignancies. In particular, it demonstrates in detail how advances in our understanding of the tumor microenvironment and molecular biology have helped to elucidate the pathogenesis of these lymphomas, improve diagnostic and prognostic accuracy, and develop novel therapies that promise improved patient outcomes. Individual chapters are devoted to particular tumor types and subtypes, and all aspects of transplantation for patients with T cell and NK cell lymphomas are discussed. As such, the book offers a valuable resource for hematologists, oncologists, hematopathologists, and all those seeking an up-to-date overview of how new, targeted therapies are delivering better disease control and improved quality of life.

ISBN: 9783319997162

Standard No.: 10.1007/978-3-319-99716-2doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

T-Cell and NK-Cell Lymphomas = From Biology to Novel Therapies /
LDR:02704nam a22003975i 4500 001 1004317
003 DE-He213
005 20200707011505.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783319997162 $9 978-3-319-99716-2
024 7 $a 10.1007/978-3-319-99716-2 $2 doi
035 $a 978-3-319-99716-2
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a T-Cell and NK-Cell Lymphomas $h [electronic resource] : $b From Biology to Novel Therapies / $c edited by Christiane Querfeld, Jasmine Zain, Steven T. Rosen.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a VIII, 287 p. 40 illus., 37 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Treatment and Research, $x 0927-3042 ; $v 176
505 0 $a Epidemiology and Pathology of T cell lymphomas/NK cell lymphomas -- Molecular and genomic landscape -- Microenvironment -- PTCL, NOS -- AITL -- ALCL -- Adult T cell leukemia/lymphoma -- NK Cell lymphomas -- Hepatosplenic T cell lymphoma -- Rare subtypes e.g. gamma-delta T cell lymphoma -- Mycosis fungoides/Sézary syndrome -- CD30+ Lymphoproliferative disorders -- Transplantation. .
520 $a In this book, a group of internationally distinguished lymphoma experts provide a comprehensive review of the most important advances in the biology, diagnosis, and therapy of T cell and NK cell malignancies. In particular, it demonstrates in detail how advances in our understanding of the tumor microenvironment and molecular biology have helped to elucidate the pathogenesis of these lymphomas, improve diagnostic and prognostic accuracy, and develop novel therapies that promise improved patient outcomes. Individual chapters are devoted to particular tumor types and subtypes, and all aspects of transplantation for patients with T cell and NK cell lymphomas are discussed. As such, the book offers a valuable resource for hematologists, oncologists, hematopathologists, and all those seeking an up-to-date overview of how new, targeted therapies are delivering better disease control and improved quality of life.
650 0 $a Oncology . $3 1253469
650 0 $a Hematology. $3 645254
650 1 4 $a Oncology. $3 593951
700 1 $a Querfeld, Christiane. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1297764
700 1 $a Zain, Jasmine. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1141747
700 1 $a Rosen, Steven T. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1297765
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319997155
776 0 8 $i Printed edition: $z 9783319997179
830 0 $a Cancer Treatment and Research, $x 0927-3042 ; $v 165 $3 1254896
856 4 0 $u https://doi.org/10.1007/978-3-319-99716-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)